Cargando…

A versatile one-step CRISPR-Cas9 based approach to plasmid-curing

BACKGROUND: Plasmids are widely used and essential tools in molecular biology. However, plasmids often impose a metabolic burden and are only temporarily useful for genetic engineering, bio-sensing and characterization purposes. While numerous techniques for genetic manipulation exist, a universal t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauritsen, Ida, Porse, Andreas, Sommer, Morten O. A., Nørholm, Morten H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540278/
https://www.ncbi.nlm.nih.gov/pubmed/28764701
http://dx.doi.org/10.1186/s12934-017-0748-z
_version_ 1783254608524607488
author Lauritsen, Ida
Porse, Andreas
Sommer, Morten O. A.
Nørholm, Morten H. H.
author_facet Lauritsen, Ida
Porse, Andreas
Sommer, Morten O. A.
Nørholm, Morten H. H.
author_sort Lauritsen, Ida
collection PubMed
description BACKGROUND: Plasmids are widely used and essential tools in molecular biology. However, plasmids often impose a metabolic burden and are only temporarily useful for genetic engineering, bio-sensing and characterization purposes. While numerous techniques for genetic manipulation exist, a universal tool enabling rapid removal of plasmids from bacterial cells is lacking. RESULTS: Based on replicon abundance and sequence conservation analysis, we show that the vast majority of bacterial cloning and expression vectors share sequence similarities that allow for broad CRISPR-Cas9 targeting. We have constructed a universal plasmid-curing system (pFREE) and developed a one-step protocol and PCR procedure that allow for identification of plasmid-free clones within 24 h. While the context of the targeted replicons affects efficiency, we obtained curing efficiencies between 40 and 100% for the plasmids most widely used for expression and engineering purposes. By virtue of the CRISPR-Cas9 targeting, our platform is highly expandable and can be applied in a broad host context. We exemplify the wide applicability of our system in Gram-negative bacteria by demonstrating the successful application in both Escherichia coli and the promising cell factory chassis Pseudomonas putida. CONCLUSION: As a fast and freely available plasmid-curing system, targeting virtually all vectors used for cloning and expression purposes, we believe that pFREE has the potential to eliminate the need for individualized vector suicide solutions in molecular biology. We envision the application of pFREE to be especially useful in methodologies involving multiple plasmids, used sequentially or simultaneously, which are becoming increasingly popular for genome editing or combinatorial pathway engineering. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0748-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5540278
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55402782017-08-03 A versatile one-step CRISPR-Cas9 based approach to plasmid-curing Lauritsen, Ida Porse, Andreas Sommer, Morten O. A. Nørholm, Morten H. H. Microb Cell Fact Technical Notes BACKGROUND: Plasmids are widely used and essential tools in molecular biology. However, plasmids often impose a metabolic burden and are only temporarily useful for genetic engineering, bio-sensing and characterization purposes. While numerous techniques for genetic manipulation exist, a universal tool enabling rapid removal of plasmids from bacterial cells is lacking. RESULTS: Based on replicon abundance and sequence conservation analysis, we show that the vast majority of bacterial cloning and expression vectors share sequence similarities that allow for broad CRISPR-Cas9 targeting. We have constructed a universal plasmid-curing system (pFREE) and developed a one-step protocol and PCR procedure that allow for identification of plasmid-free clones within 24 h. While the context of the targeted replicons affects efficiency, we obtained curing efficiencies between 40 and 100% for the plasmids most widely used for expression and engineering purposes. By virtue of the CRISPR-Cas9 targeting, our platform is highly expandable and can be applied in a broad host context. We exemplify the wide applicability of our system in Gram-negative bacteria by demonstrating the successful application in both Escherichia coli and the promising cell factory chassis Pseudomonas putida. CONCLUSION: As a fast and freely available plasmid-curing system, targeting virtually all vectors used for cloning and expression purposes, we believe that pFREE has the potential to eliminate the need for individualized vector suicide solutions in molecular biology. We envision the application of pFREE to be especially useful in methodologies involving multiple plasmids, used sequentially or simultaneously, which are becoming increasingly popular for genome editing or combinatorial pathway engineering. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0748-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-02 /pmc/articles/PMC5540278/ /pubmed/28764701 http://dx.doi.org/10.1186/s12934-017-0748-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Technical Notes
Lauritsen, Ida
Porse, Andreas
Sommer, Morten O. A.
Nørholm, Morten H. H.
A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
title A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
title_full A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
title_fullStr A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
title_full_unstemmed A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
title_short A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
title_sort versatile one-step crispr-cas9 based approach to plasmid-curing
topic Technical Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540278/
https://www.ncbi.nlm.nih.gov/pubmed/28764701
http://dx.doi.org/10.1186/s12934-017-0748-z
work_keys_str_mv AT lauritsenida aversatileonestepcrisprcas9basedapproachtoplasmidcuring
AT porseandreas aversatileonestepcrisprcas9basedapproachtoplasmidcuring
AT sommermortenoa aversatileonestepcrisprcas9basedapproachtoplasmidcuring
AT nørholmmortenhh aversatileonestepcrisprcas9basedapproachtoplasmidcuring
AT lauritsenida versatileonestepcrisprcas9basedapproachtoplasmidcuring
AT porseandreas versatileonestepcrisprcas9basedapproachtoplasmidcuring
AT sommermortenoa versatileonestepcrisprcas9basedapproachtoplasmidcuring
AT nørholmmortenhh versatileonestepcrisprcas9basedapproachtoplasmidcuring